IVI RMA GLOBAL
Marco Toschi serves as the Lab Director at IVI RMA GLOBAL in Rome, Italy, overseeing the IVF – PGD lab since March 2019. Prior experience includes roles as a Staff Associate and Clinical Senior Embryologist at Weill Cornell Medicine from November 2016 to February 2019 and as a Senior Embryologist while freelancing and at Inebir from 2015 to 2016. Marco co-founded BIONAC in 2009, where responsibilities included designing and implementing innovative IVF laboratory practices and leading laboratory training programs until February 2015. Prior to BIONAC, Marco held positions in clinical embryology and research, including at Tecnobios Procreazione, Weill Cornell Medical College, and the University of Bologna, where achievement included winning a Rita Levi Montalcini foundation grant. Marco holds a PhD in Medicine from the University of Valencia and a Master’s degree in Reproductive Biotechnologies from Universita di Teramo, complemented by a degree in Biological Sciences from Universita degli studi di Milano.
This person is not in any teams
This person is not in any offices
IVI RMA GLOBAL
3 followers
IVIRMA Global is the world’s premier fertility group that leads the industry in research, success rates and patient care. From clinical excellence, to research and innovation, to teaching the next generation of reproductive endocrinologists, to advancing cutting edge protocols, standards and practices in the field. The acronyms IVI and RMA represent the two best assisted reproduction groups in Europe and the U.S., respectively. Together, they have since the beginning of the nineties been setting the standard in the field of reproduction, until in February 2017 they decided to merge to form the largest Reproductive Medicine group in the world. IVI was founded in 1990 by Professors José Remohí and Antonio Pellicer, and became a leader in fertility treatment in Europe and Latin America. RMA was founded in 1999 by Drs. Paul Bergh, Richard Scott and Michael Drews, quickly becoming a leader in reproductive medicine in the United States. IVI and RMA both place great importance on research, high-quality scientific results, and a common culture with a single objective: to achieve the best results for patients. • 75 Clinical Offices & 28 Labs in 9 Countries • +465 Physicians & Embryologists • +2300 Employees • +100 babies born daily thanks to IVIRMA Research & Development… • +2500 Publications • 69 Researchers • 7 Researcher centers